Practical Guidance, Clinical Photo Archive and Headlines for Primary Care Clinicians
In the last few months, the FDA has approved almost a dozen medications for a variety of primary care disorders.
Recent Content
Glucagon-like peptide-1 receptor agonists represent a novel class of antihyperglycemic agents that have a cardiac-friendly profile.
Two small children, two opportunities to administer the live MMR vaccine. Who gets the shot and who does not?
For many obese adults, diet and exercise are not enough to achieve durable weight loss. Three drugs are approved in the US as adjunctive therapy for obesity management. Weigh in with what you know with answers to these 3 questions.
Here’s a call to neither “praise nor bury” the annual physical, but rather to determine its scientific efficacy in specific contexts.
Brief exposure to a variety of modifiable factors—physical and psychosocial—increases the risk of back pain.
There are conditions under which the MMR vaccine should not be given—even when a parent begs. Which of the children in these 4 scenarios should not receive the vaccination?
The incidental finding was noted during screening endoscopy for Barrett's esophagus. Can you answer these 3 questions on next steps and management of the case.
Parental fears and misinformation about vaccines can be overcome, says this expert. Here are some suggestions.
A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).
Better understanding of migraine causes and related issues could result in enhanced patient care and prevention, but clinicians face some serious challenges—here are 5.
In the past few months, the FDA has approved a number of drugs for a variety of primary care disorders. Here’s a look at 11 of the newest.
When parents play out worst case scenarios in protest against routine vaccination, maybe one or two of these 6 options for response will come in handy.
